Media
Dr. Oz Show
The Biggest Advances To Stop Your Chronic Headaches
Dr. Audrey Halpern reviewed Nerivio on the Dr. Oz Show and explored the wearable neuromodulation options available to assist with migraine relief and prevention.
More
CNBC TV 18 - India
Review of Dr Reddy’s Nerivio Migraine Device: Medication-free headache relief
Dr Reddy’s Nerivio, a USFDA-approved migraine relief device, offers a convenient, pulse-based treatment through ‘remote electrical neuromodulation (REN).’ Despite occasional efficacy variations, it proves beneficial, especially for severe attacks. Priced at ₹16,000, it requires a prescription and offers an alternative to traditional migraine medications.
Read More
Fierce Biotech
Nerivio Neuroband named as winner of Fierce Biotech’s Medical Innovation Device award
Theranica’s Nerivio, a prescription wearable device used to mitigate migraines, went from being a reactive approach of treating symptoms to a proactive tool for helping prevent them. Earlier this year and just a few months after submitting a new 510(k) to expand indications for the technology, the FDA cleared the device for people who experience […]
Read More
How To Treat A Migraine
A migraine is a type of headache that causes throbbing pain, usually on one side of the head. But a migraine is much more than a headache. It can cause intense pain, nausea, vomiting, sensitivity to light, and sensitivity to sound that can last for several days. The throbbing pain and other migraine symptoms can […]
More
Fast Company
Theranica Named to Fast Company’s Annual List of the Next Big things in HealthTech for 2023
For treating adolescent migraines. Migraines are debilitating, but most treatment options focus on adults. Theranica‘s Nerivio wearable is targeting the 100 million adolescents worldwide who are impacted by migraines. The company’s FDA-approved treatment uses a smartphone app and a product that wraps around a user’s upper arm to trigger a natural process in the brain to […]
Read More
What Causes a Migraine
A migraine is a type of headache that causes throbbing pain, usually on one side of the head. Typically, the migraine pain is accompanied by other symptoms such as nausea, vomiting, sensitivity to light, or sensitivity to sound. The causes of migraine are not fully understood, but we know that genetics and environmental factors play […]
More
MedCity News
Moving beyond one-dose-fits-all: How medtech and personalized dosing can improve outcomes
Several medical devices using electrical neuromodulation have been developed to treat pain, spinal injuries, epilepsy, migraine, and other conditions. More than just a new technological solution, the possibility presented by these devices is significant.
More
Local 10 News
New device offers alternative for migraine relief
Recent research is showing that a non-systemic treatment can provide relief from migraine headaches, which affect an estimated 12% of Americans. Dr. Teshamae Monteith is an associate professor of clinical neurology and chief of the headache division at the University of Miami Health System. Monteith said a study involving adolescents found that an app-controlled neuromodulation […]
More
migraine.com
Real-World Experience with Nerivio
Tom Picerno, formally diagnosed with chronic migraine, tells about his experience with Nerivio: "...I find it comforting to know that I have non-drug related therapies in my arsenal of migraine care options. I know for me it has been used effectively to replace my abortive triptans..."
More
Fox News
17-year-old finds miracle migraine treatment at Kansas City hospital
A teenager and her mom are driving more than 300 miles from Arkansas to Kansas City for what they call a miracle treatment. With migraines so bad that 17-year-old Sonja Burnett said she could barely walk anymore, every single mile of the trek will be worth it. After nearly 4 years of not leaving her […]
More
Practical Pain management
Nerivio Gets FDA Nod for Use in Migraine Prevention
The FDA has approved Nerivio as a preventive treatment for migraine, with or without aura, in adults and children 12 years old and older. The non-invasive prescription wearable had already been approved as a treatment for acute migraine in adolescents and adults. The device’s dual-use approval opens up new options for migraine care in adolescents and adults.
More
The American Israel Public Affairs Committee
AIPAC Briefing: Treating Migraines Digitally
Theranica CEO Alon Ironi explains how his innovative technology, Nerivio, alleviates migraines and other ailments—all without the use of prescription drugs. Theranica is an Israeli biomedical technology company.
More
Fierce Biotech
Theranica aims to stretch FDA nod with study of neuromodulation device as preventive migraine treatment
With almost two more years having passed since the company successfully lobbied the FDA to expand its Nerivio neuromodulation armband indication as an acute migraine treatment from adults only to all patients aged 12 and older with episodic or chronic migraine, Theranica is once again asking the agency to expand the device’s approved usage. Its […]
More
Physician's Weekly
REN: A Novel Approach to Migraine Treatment
Evidence suggests that pharmacologic agents often used to treat migraine may at times be ineffective, poorly tolerated, contraindicated, and—if used too frequently—can cause possible medication overuse headache, migraine chronification, and notable medical complications. A significant unmet need exists for effective and well-tolerated non-pharmacologic acute migraine therapy, according to Alan M. Rapoport, MD.
More
Mediaplanet’s Neurological Disorders campaign
You can find us in Mediaplanet’s Neurological Disorders campaign
Millions of Americans suffer from neurological disorders yearly, but progress is being made in managing neurological health and improving quality of life for patients. Through interviews and articles, this campaign raises awareness of neurological disorders including Alzheimer’s, Parkinson’s, epilepsy, migraine, and more. The campaign was distributed through USA TODAY and is published online
More
Health Tech World
NewsInterview: The drug-free migraine treatment that’s got big pharma worried
Theranica says it has demonstrated clinical evidence equivalent to commonly prescribed medications and serves more than 25,000 people with migraine, including adolescents and adults, in the USA. Health Tech World speaks with Alon Ironi, CEO of Theranica, to learn more about the wearable that’s got big pharmaceutical companies worried.
More
Fast Company
Theranica Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2020
Theranica, the developer of Nerivio, has been ranked fourth in Fast Company's Biotech category on the 2020 Most Innovative Companies List. The prestigious annual list identifies companies making the most profound impact on their industry.
More
Migraineur Magazine
Nerivio is Chosen for “Treatment of the Month”
Migraineur Magazine chooses Nerivio for "Treatment of the Month". Choosing a drug-free therapy is a strong statement. Someone is putting patients first.
More
Channel 3 Eyewitness News
Wireless Nerivio Helps Manage Migraines
Connecticut’s Channel 3 Eyewitness News segment focus on the Nerivio device for easing migraine pain. Dr. Brian Grosberg, medical director of the HHC headache program at Hartford healthcare CT, explains the mechanism and benefits of Nerivio.
More
Good Morning America
Good Morning Nerivio!
Good Morning America hosted a 3-day segment on migraine, in which Nerivio, one of Time’s best inventions in 2019, was highlighted as a solution for migraine relief.
More
CBS This Morning
Taking Migraine Seriously
Dr. William Young, a neurologist and headache specialist at Thomas Jefferson University Hospital in Philadelphia, talks about migraine and presents Nerivio on CBS This Morning.
More
NoCamels
Migraine Zapping Device Offers Hope for Sufferers
Alon Ironi, Therania’s co-founder, CEO, and president, talks about Nerivio and the history behind its development.
More
The Jerusalem Post
Israeli Bio-Medical Tech Company Recognized as ‘Game Changer for 2020’
CB Insights selected 36 global companies across 12 categories and identified emerging trends to watch and high momentum companies pioneering technology with the potential to transform society and economies for the better. Theranica was recognized for combining neuromodulation therapy with wireless technology to address medical conditions such as migraines and helping to create a drug-free future for chronic illness.
More
ILTV
Alon Ironi Discusses the Science Underlying Nerivio
Theranica CEO, Alon Ironi, sits down with ILTV to discuss the science behind Nerivio and its use as a first-line complementary migraine therapy.
More
The New York Times
New Hope for Migraine Sufferers
There are now a number of medications that may prevent or alleviate migraines, as well as a wearable nerve-stimulating device that can be activated by a smartphone.
More
NBC
Dr. Chua introduces Nerivio
Dr. Abigail Chua, a neurologist and headache specialist at the Hartford Headache Center, discusses the challenges of pharmaceutical treatments for migraine and presents Nerivio, a cutting edge technology for acute treatment of migraine
More
Clinical Research News
Will Wearable Device Become First-line Treatment For Migraines?
Israeli biomedical technology company Theranica is intent on making its new-to-market remote electrical neuromodulation wearable device a first-line treatment for migraines of every type.
More
NeurologyLive
Experts Weigh In On Early Clinical Experience With Nerivio in Acute Migraine
With Theranica’s Nerivio acute migraine device named a top invention of the year, three experts in migraine shared their insight into its clinical application in the early days of its availability, with varying experiences.
More
Sponsor (Hebrew Article)
An Israeli Startup That Develops A device for Acute Treatment of Migraine Is Named in TIME’s List of 100 Best Inventions of 2019
The device is expected to be approved in Israel on April 2020.
More
Scientific American
Treating Chronic Pain in the Right Place: Remotely
Dr. David Yarnitsky presents the latest research in neuromodulation and pain mechanisms, which has recently resulted in a new non-pharmacological option for migraine patients.
More
Live at AHS
Dr. Silberstein explains about Nerivio which was Named in TIME’s List of 100 Best Inventions of 2019
Dr. Silberstein explains Paula Dumas with Migraine World Summit about Nerivio at the American Headache Society Meeting.
More
Time
A Year After Approval, Migraine Drugs Are Changing Lives. But Insurance Battles Are Creating a Whole New Headache
An important article in TIME magazine regarding migraine drugs and their…
More
Jerusalem Post
Disrupting the migraine business
Hillel’s Tech corner:Theranica, a biomedical technology company founded in 2016 and based in Netanya that is developing advanced “electroceuticals” – devices that treat ailments with electrical impulses – for…
More
TimeaAZ Family
We’re not the only ones excited about Nerivio!
Happy to see that everyone is just as excited as we are for the Nerivio! It really is a game changer!
More
NeurologyLive
Dr. Brian Grosberg: Nerivio Device for Acute Migraine Treatment
At the American Headache Society’s 2018 Scottsdale Headache Symposium in Arizona, Grosberg sat with NeurologyLive to discuss Nerivio and its potential in the treatment of acute migraine. He noted its comparable outcomes to the pharmacologic acute treatments.
More
MobiHealthNews
Building a future of safe and drug-free alternatives to painkillers
An interview with Alon Ironi, CEO & co-founder of Theranica.
Imagine a future where pain can be managed or alleviated using a combination of digital technologies and devices, greatly reducing the risks brought about by conventional painkillers. That is what Alon Ironi, CEO & co-founder of Israel-based biomedical technology company Theranica hopes to achieve.
More
Israel21c
Can an electronic patch reduce the pain of migraines?
It looks like a high-tech version of a nicotine patch, but Theranica Bio-Electronics’ wearable device has a different purpose: to knock out migraines… at least temporarily.
Inside Theranica’s Nerivio Migra patch are tiny electrodes that deliver a small electrical jolt to your body to mitigate headaches and other acute pains through what’s known as CPM (conditioned pain modulation).
More
Investing News
Theranica Bioelectronics Hopes to Take Migraine Device Global
Privately owned Theranica Bioelectronics is aiming to reshape the way migraines are treated in patients all around the world.
The company, which was founded three years ago, is using advanced neuromodulation therapy with wireless technology to develop electroceuticals for migraines and other pain disorders.
More
Everyday Health
FDA Greenlights New Wearable Device for the Treatment of Acute Migraine
The U.S. Food and Drug Administration (FDA) cleared the way for a first-in-category product that uses remote electrical neuromodulation to treat acute migraine pain. Worn on the upper arm, the smartphone-controlled Nerivio Migra uses electronic pulses to help “turn off” migraine pain.
More
WebMD
FDA OKs Wearable Device for Migraine Pain
May 29, 2019 -- The FDA has cleared a noninvasive device to relieve acute migraine pain.
Nerivio Migra is a "first-in-category product," according to Theranica, the company that makes it. It is worn on the upper arm and uses smartphone-controlled electronic pulses to relieve migraine pain.
More
6abc.com
FDA approves wearable migraine pain device
BETHESDA, Md. (WPVI) -- The government has OK'd a new non-invasive device to relieve the pain of acute migraine.
More
MedCity News
Israeli startup gets FDA nod for neuromodulation device to treat migraines
Nerivio Migra consists of a bioelectric patch which is placed on the upper arm and an associated smartphone app which controls the electrical impulses and records data.
More
MassDevice
Omron joins $35m Theranica Series B
Theranica said today that Omron‘s (TYO:6645) venture arm joined a $35 million Series B financing round to support its remote neuromodulation technology.
Israel-based Theranica is developing the Nerivio Migra neurostimulation patch intended to treat migraine headache, which is currently under FDA review.
More